(MedPage Today) — Use of GLP-1 receptor agonists was associated with a lower risk of mortality for dialysis patients with type 2 diabetes, according to a retrospective cohort study of Medicare enrollees.
Among over 151,000 patients, use of GLP…
Source link : https://www.medpagetoday.com/meetingcoverage/obesityweek/118321
Author :
Publish date : 2025-11-05 18:12:00
Copyright for syndicated content belongs to the linked Source.
